Opinion

Video

Clinical Perspectives: Use of CDK4/6i After CDK4/6i

Panelists discuss potential treatment options for patients following progression on CDK4/6 inhibitors (i) in HR+/HER2– metastatic breast cancer.

Related Videos
5 experts are featured in this series
5 experts are featured in this series
Eric Winer, MD
2 expert is featured in this series.